GSK Investigational Site
Lake Charles, Louisiana 70605
1 studies enrolling now · 16 studies all time
What they study most
Acute Coronary Syndrome, Arthritis, Rheumatoid, Bipolar Disorder, Diabetes Mellitus, Type 2, Lung Cancer, Non-Small Cell, Non-Small-Cell Lung Cancer, Pulmonary Disease, Chronic Obstructive
Studies at this site
- eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation — Recruiting now
- Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA) — Stopped early
- Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs) — Stopped early
- Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus — Completed
- Safety and Efficacy Study of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus — Completed
- Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer — Completed
- Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide — Completed
- Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive — Completed
- The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial — Completed
- Safety and Efficacy of Albiglutide in Type 2 Diabetes — Completed
- Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes — Completed
- A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes — Completed
- A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes — Completed
- Safety and Efficacy Study of Albiglutide in Type 2 Diabetes — Completed
- Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin — Completed
- Bipolar Study in Adults at Least 18 Years of Age — Completed